Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-29,556
Closed -$4.37M 188
2016
Q4
$4.37M Hold
29,556
0.4% 87
2016
Q3
$4.89M Hold
29,556
0.42% 74
2016
Q2
$4.44M Hold
29,556
0.41% 79
2016
Q1
$4.42M Sell
29,556
-14,093
-32% -$2.09M 0.42% 73
2015
Q4
$7.13M Hold
43,649
0.61% 52
2015
Q3
$5.84M Sell
43,649
-2,351
-5% -$371K 0.55% 68
2015
Q2
$6.97M Buy
46,000
+2,700
+6% +$433K 0.58% 58
2015
Q1
$7.11M Buy
43,300
+3,300
+8% +$520K 0.56% 55
2014
Q4
$6.42M Sell
40,000
-9,495
-19% -$1.48M 0.49% 74
2014
Q3
$6.93M Buy
49,495
+5,445
+12% +$711K 0.55% 64
2014
Q2
$5.22M Buy
44,050
+7,500
+21% +$868K 0.43% 78
2014
Q1
$4.41M Hold
36,550
0.38% 88
2013
Q4
$4.22M Sell
36,550
-28,450
-44% -$3.24M 0.37% 76
2013
Q3
$7.36M Hold
65,000
0.62% 52
2013
Q2
$6.43M Buy
+65,000
New +$6.75M 0.58% 57

Other funds holding AMGN

Robeco Schweiz's AMGN Position: Q1 2017 in Review

Robeco Schweiz sold out of Amgen (AMGN) in Q1 2017, closing a stake of 29,556 shares — an estimated $4.37M sold.

Robeco Schweiz first reported a position in AMGN in Q2 2013 and held it in 15 quarters. The position peaked at $7.36M in Q3 2013. 1,600 funds tracked by Wall St. Rank hold AMGN as of Q1 2017.

  • Robeco Schweiz reported no remaining Amgen position as of Q1 2017 after selling out during the quarter.
  • Robeco Schweiz sold 29,556 Amgen shares in Q1 2017, an estimated $4.37M.
  • Robeco Schweiz first reported a position in Amgen in Q2 2013 and held it in 15 quarters.
  • Robeco Schweiz's Amgen position peaked at $7.36M in Q3 2013.
  • 1,600 funds tracked by Wall St. Rank held Amgen as of Q1 2017.

Based on Robeco Schweiz's 13F filing for Q1 2017, filed 10 May 2017.